ON
← Back to feed
Getting there faster with new technology
Austria🏛️ Politics5 days ago

Getting there faster with new technology

The article reports on the Austrian Phoenix Startup Prize, which this year highlighted sustainability-focused innovations. Among the winners was imd Biotech, a spin-off from the University of Vienna, which won in the Prototype category for its diagnostic platform 'rappid'. This technology allows for rapid detection of bacterial contamination in food, reducing the time needed for analysis from days to hours. The system uses simultaneous incubation and real-time detection, enabling immediate results without requiring trained lab personnel. The team behind 'rappid' includes experts in business development, finance, IT, and sales, and they are currently working on expanding the platform's capabilities to detect other pathogens like E. coli and Salmonella.

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

1 reports

Kurier logoKurierParty-alignedCenter5 days ago
Getting there faster with new technology

The article reports on the Austrian Phoenix Startup Prize, which this year highlighted sustainability-focused innovations. Among the winners was imd Biotech, a spin-off from the University of Vienna, which won in the Prototype category for its diagnostic platform 'rappid'. This technology allows for rapid detection of bacterial contamination in food, reducing the time needed for analysis from days to hours. The system uses simultaneous incubation and real-time detection, enabling immediate results without requiring trained lab personnel. The team behind 'rappid' includes experts in business development, finance, IT, and sales, and they are currently working on expanding the platform's capabilities to detect other pathogens like E. coli and Salmonella.

Bias read (Center): The article presents the innovation and benefits of 'rappid' objectively, focusing on technical details and practical applications without overtly praising or criticizing the technology or its implications for public health policy. It does not take a clear ideological stance on the broader issue of食

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.

Become a Supporter

Related stories